• Home
  • Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma.

Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma.

Author List
Yang YW, Marrufo A, Chase J, Woodard GA, Jablons DM, Lemjabbar-Alaoui H
Publication
Experimental lung research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/146560159
Publication Year
2020
PubMed ID
33107354
Publication Title
Yang YW, Marrufo A, Chase J, Woodard GA, Jablons DM, Lemjabbar-Alaoui H. Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma. Exp Lung Res. 2021 02; 47(1):9-25.